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ABSTRACT
Raised leptin levels have been reported in placentae and serum of women with
elevated blood pressure and proteinuria during pregnancy. The role of leptin in this
however remains unclear. ACE2 is a new member in RAAS, which is reported to
have hypotensive and anti-inflammatory effect and its suppression leads to increased
blood pressure and endothelial activation. Therefore, this study investigated the effect
of leptin and xanthenone (ACE2 activator) administration on systolic blood pressure
(SBP), proteinuria and serum markers of endothelial activation during pregnancy in
Sprague-Dawley rats. Eighty female Sprague-Dawley rats, aged 12-13 weeks were
randomised into 10 groups, Group 1 acted as a control non-pregnant group and given
saline (NSNP). Group 2, control pregnant rats, was given saline (NSP), group 3 was
given 60 ug / kg /day of leptin starting from the 1st day of pregnancy (LD1-60), group
4, was given 60 ug / kg /day ofleptin starting from the 10th day of pregnancy (LDI0),
group 5, given leptin from day 16 of pregnancy (LD16). Group 6 (L14D-60), given
leptin approximately 14 days before pregnancy, Group 7 was non-pregnant rats
receiving leptin for a period of 20 days (LNP). Group 8, given 60 ug / kg /day of
leptin with 600 ug / kg /day of xanthenone (XNT), an ACE2 stimulant from day -1 of
pregnancy (L+ACE2a), while group 9 was given 600 ug / kg /day of XNT alone
starting from day 1 of pregnancy (ACE2a). Group 10 was given 120 ug / kg /day of
Leptin starting from day 1 of pregnancy (LD1-l20). SBP, serum ACE, ACE2,
endothelin-l, E-selectin and ICAM-1 levels were estimated. ACE2, endothelin-l, E-
selectin and ICAM-l gene expressions were determined in the kidney and aorta. Data
were analysed using ANOYA and post-hoc analysis, data are presented as mean ±
S.E.M. Compared to group 1, SBP was higher in the leptin only treated group
(P<O.OOI) and lower in rats treated with xanthenone alone (P< 0.01). ACE2 activity
and expression were lower in leptin only treated rats (P<O.05). Urine protein
excretion, serum endothelin-l, serum E-selectin, and ICAM-1 levels were
significantly higher than controls in leptin only treated rats (P<0.05) but not in the
others. It seems, leptin administration during pregnancy significantly increases SBP,
urinary protein excretion, levels and expression of markers of endothelial activation,
but decreases the level and expression of ACE2. These effects are prevented by
xanthenone, implicating the role of ACE2 in leptin-induced raised blood pressure and
proteinuria during pregnancy. However, further studies are required to examine the
underlying mechanism responsible for this and its relevance to preeclampsia in
humans.
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